Background: GV sPLA 2 hydrolyzes bacterial phospholipids. Myeloid and non-myeloid cells in lung express GV sPLA 2 . Result: Deletion of GV sPLA 2 impairs leukocyte accumulation and bacterial clearance after lung infection with E. coli. Conclusion: GV sPLA 2 regulates the innate immune response to E. coli pneumonia. Significance: Inhibiting GV sPLA 2 to treat inflammatory diseases could impair the immune response to bacterial infection.